Description

Program provides daily or weekly email reports for the most current changes in patient assistance programs. Program alert service allows subscribers to receive important PAP updates as they become available, including contact information, changes, new, closed or merged programs, drug additions/removals, new or changed applications and eligibility criteria changes to programs. Once a month, subscribers will also receive a list of the brand name drugs that have a new generic equivalent approved by the FDA. The information includes the brand name, generic drug name with its formulation and strength, generic manufacturer and approval date. To sign up for PAPUS, community members should visit the subscription center.

What's Here